Published in Scand J Immunol on April 01, 1984
Laccase from Sycamore Maple (Acer pseudoplatanus) Polymerizes Monolignols. Plant Physiol (1992) 1.53
Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages. Immunology (1985) 1.20
Models of cell differentiation in conidial fungi. Microbiol Rev (1986) 1.15
Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br J Cancer (1986) 1.05
HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease. Clin Exp Immunol (1987) 1.02
Sequential determination of lineage potentials during haemopoiesis. Br J Cancer (1985) 0.79
Deficient expression of MHC class II antigens in some cases of human B cell leukaemia. Clin Exp Immunol (1986) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol (1988) 26.07
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
International uniform response criteria for multiple myeloma. Leukemia (2006) 17.78
Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell (1978) 14.82
A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods (1981) 10.77
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res (2001) 6.93
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Fading of immunofluorescence during microscopy: a study of the phenomenon and its remedy. J Immunol Methods (1982) 5.95
Antibody to smooth muscle in patients with liver disease. Lancet (1965) 5.71
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ (2000) 5.64
Microstructural maturation of the human brain from childhood to adulthood. Neuroimage (2008) 5.30
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy. Blood (2000) 4.37
Identification of an SCF ubiquitin-ligase complex required for auxin response in Arabidopsis thaliana. Genes Dev (1999) 4.35
Epidemic Diarrhoea and Vomiting. Br Med J (1945) 4.29
Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett (1985) 4.23
Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci (2000) 4.13
Rural background and clinical rural rotations during medical training: effect on practice location. CMAJ (1999) 4.12
Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08
Purification of human T and B lymphocytes. J Immunol (1974) 4.00
Clinical effects and treatment of imipramine and amitriptyline poisoning in children. Br Med J (1967) 3.47
Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients. Am J Psychiatry (1990) 3.45
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia (2008) 3.41
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells. Nature (1974) 3.37
Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol (1983) 3.23
Spatially independent activity patterns in functional MRI data during the stroop color-naming task. Proc Natl Acad Sci U S A (1998) 3.18
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. Am J Med (2000) 3.16
Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol (1982) 3.12
Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12
The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg (1994) 3.06
Timer: a new objective measure of consultation content and its application to computer assisted consultations. Br Med J (Clin Res Ed) (1986) 3.00
Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods (1977) 2.97
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Clinically relevant end points and new drug approvals for myeloma. Leukemia (2007) 2.91
Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet (1997) 2.91
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Monoclonal antibodies (McAbs) to determinants on human gamma chains: properties of antibodies showing subclass restriction or subclass specificity. Immunology (1982) 2.79
Computer assisted screening: effect on the patient and his consultation. Br Med J (Clin Res Ed) (1985) 2.76
Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol (1991) 2.71
Cell surface markers for human T and B lymphocytes. Eur J Immunol (1974) 2.70
Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev (2001) 2.69
Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria. Parasitol Today (1993) 2.64
Killing of Mycobacterium microti by immunologically activated macrophages. Nature (1981) 2.62
The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther (2007) 2.59
Germinal centres in T-cell-dependent antibody responses. Immunol Today (1992) 2.47
Computers in the surgery. The patient's view. Br Med J (Clin Res Ed) (1984) 2.43
Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart (2004) 2.38
Understanding men's health and illness: a gender-relations approach to policy, research, and practice. J Am Coll Health (2000) 2.34
Quantitative studies of immunofluorescent staining. I. Analyses of mixed immunofluorescence. Immunology (1967) 2.32
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications. Leukemia (2001) 2.30
Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers' fascia. Br J Surg (2004) 2.26
Enhanced uptake by guinea-pig macrophages of radio-iodinated human aggregated immunoglobulin G in the presence of sera from rheumatoid patients with cutaneous vasculitis. Clin Exp Immunol (1975) 2.24
Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science (1987) 2.24
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Parental influences on children's eating behavior and relative weight. J Appl Behav Anal (1983) 2.21
In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature (1993) 2.19
Renal insufficiency in treated essential hypertension. N Engl J Med (1989) 2.17
Palindrome resolution and recombination in the mammalian germ line. Mol Cell Biol (1997) 2.17
Enumeration of absolute numbers of T and B lymphocytes in human blood. Scand J Immunol (1974) 2.16
Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth (2002) 2.15
Oncogenic transformation by vrel requires an amino-terminal activation domain. Mol Cell Biol (1990) 2.15
Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15
Underascertainment of child abuse mortality in the United States. JAMA (1999) 2.11
Adaptation of a microimmunofluorescence test to the study of human Rickettsia tsutsugamuskh antibody. Am J Trop Med Hyg (1976) 2.10
Assessing the consultation: methods of observing trainees in general practice. Br Med J (Clin Res Ed) (1984) 2.09
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP). Heart (2007) 2.06
The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications. Oncogene (2001) 2.04
Prohibitin, an evolutionarily conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol (1991) 2.04
Women need to be warned about dangers of hormone replacement therapy. BMJ (1997) 2.02
A new fluorescent antibody method: mixed antiglobulin immunofluorescence or labelled antigen indirect immunofluorescence staining. Nature (1965) 1.98
Severe hepatitis E infection during pregnancy. J Viral Hepat (1997) 1.96
Suxamethonium in bunged cannulae. Anaesth Intensive Care (1991) 1.94
Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res (1986) 1.94
The transformation in vitro of peripheral lymphocytes of some laboratory animals. Immunology (1965) 1.91
Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis. Clin Immunol Immunopathol (1975) 1.90
A novel Bcl-2/Bcl-X(L)/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. Oncogene (2006) 1.89
New immunofluorescent blood test for gluten sensitivity. Arch Dis Child (1981) 1.88
Allele loss on short arm of chromosome 17 in breast cancers. Lancet (1988) 1.86
A semiautomatic procedure for routine screening by immunofluorescence techniques. Ann N Y Acad Sci (1971) 1.84
The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum (1974) 1.84
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet (2006) 1.83
Multispot immunofluorescence: a simple semi-automatic method of processing large numbers of tests. J Clin Pathol (1970) 1.80
Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis (1981) 1.79
Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77
ABC of breast diseases. Breast cancer--epidemiology, risk factors and genetics. BMJ (1994) 1.77
The detection of antibodies to Mycobacterium tuberculosis by microplate enzyme-linked immunosorbent assay (ELISA). Tubercle (1976) 1.77
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
CD23: a multi-functional receptor/lymphokine? Immunol Today (1989) 1.76
Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology (1986) 1.75
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
Ligation of the CD23,p45 (BLAST-2,EBVCS) antigen triggers the cell-cycle progression of activated B lymphocytes. Eur J Immunol (1986) 1.74